▲ Up
 
09:33 30-08-2015
MAIN АКИpress CA-News
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanMongoliaWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug to crack resistant TB

Bishkek (AKIpress) - doctor-x-ray Florian von Groote-Bidlingmaier, medical director of TASK Applied Science, a research unit collaborating with Stellenbosch University, told doctors yesterday about trials of new drugs that might offer a lifeline to patients with drug-resistant TB, Times Live reported.

He was speaking at the World TB Day Symposium, convened by the National Institute for Communicable Diseases, in Johannesburg.

Half-a-million South Africans contract TB every year and one in 25 is likely to develop a form of the disease resistant to treatment. Drug-resistant TB kills at least one in five of the people who contract it.

Most TB drugs have been in use for at least 50 years, Von Groote-Bidlingmaier said, but the development of a new medicine took many years and could cost as much as 10 billion rand ($920.3 million).

It can be years before patients gain access to a new medicine. For example, the drug bedaquiline was developed in 2005 but almost 10 years later it is available to only 200 patients in South Africa in a monitored program with strict eligibility criteria.

Von Groote-Bidlingmaier said that delamanid, conditionally approved by the European Medicines Agency recently, was being tested at three sites in South Africa and abroad. The current trials, if successful, are the last step before the drug is registered.

“TB is not treated with a single drug. There is a need for further trials to test new drugs in combination to see if we can find a better treatment regimen.”

South Africa is the world leader in the exploitation of the GeneXpert machine to detect TB much more quickly. But a study has shown that, though detection has improved, patients are no more likely to start and see their treatment through to completion.

TASK Applied Science performs clinical trials in tuberculosis (TB) in Cape Town, South Africa. TASK can provide assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis.


Twitterfacebookprint
13:01 25.03.2014
LATEST NEWS
18:08 Scientists discover bigger version of Great Barrier Reef17:48 CIS commission on peaceful use of atomic energy to meet in November 201517:35 Greece names new prime minister17:23 Kyrgyzstan reduces trade with Uzbekistan almost two times17:15 Khan Bank of Mongolia signs cooperation agreement with Hungarian National Trading House17:09 Washington welcomes agreement to establish uranium bank in Kazakhstan16:49 U.S. Assistant Secretary of State for International Security and Nonproliferation still in Kazakhstan16:46 Kyrgyzstan to launch Kambar-Ata-2 HPP at full capacity with operationalization of Datka-Kemin power transmission line16:35 Mongolia delivers humanitarian aid to Myanmar16:32 Student dies falling from 19th floor of Twin Towers in Dushanbe16:01 Facebook hits 1 billion users in a single day15:58 Presidents of Turkmenistan and Afghanistan sign number of agreements on cooperation15:53 Biometric voter identification guarantees transparent and open elections – OSCE Secretary General15:38 Constitutional principle in Kazakhstan to be gradually supplemented by social support measures – Nazarbayev15:26 Asian shares extend global rally after upbeat U.S. economic data calm sentiment15:24 Gazprom Management Committee Chairman to visit Bishkek15:23 Foreign Minister: Kazakhstan encourages civilian nuclear energy with security in mind15:18 Lenin Peak being cleaned from trash remaining since collapse of Soviet Union15:18 Experts from Uzbekistan and Kyrgyzstan discuss border issues14:59 Overhead power transmission line from Batken to Tajikistan to be built under CASA-1000 Project
Astana
+24° C
Ashgabat
+31° C
Bishkek
+26° C
Dushanbe
+26° C
Tashkent
+29° C
exchange rates
 
73.50
65.10
10.19
0.98
268.37
237.66
37.21
3.56
6.85
6.26
1.01
0.12
2710.18
2512.73
405.44
50.01
3.91
3.50
0.55
0.05

© AKIpress News Agency - 2001-2015. All rights reserved
Republication of any material is prohibited without a written agreement with AKIpress News Agency. Any citation must be accompanied by a hyperlink to www.akipress.com.
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75